The mechanism of the bronchospasmolytic effect of HOE 234 4-(2-oxo-1-p
yrrolidinyl)-6-phenylsulphonylchromane hemihydrate), a novel opener of
ATP-sensitive potassium channels, has been studied by in-vitro testin
g in ring preparations of trachea and different parts of the principle
bronchus of guinea-pigs, using methacholine, histamine and KCl as pre
constrictors. The contribution of prostanoids was estimated in the pre
sence and absence of indomethacin. Regional differences in the broncho
dilatory effect of HOE 234 were compared with that of salbutamol. HOE
234 had a concentration-dependent relaxing effect on the smooth muscle
preparations. Tn the absence of indomethacin no regional differences
were seen for the effect of HOE 234 against the metacholine or KCl pre
constriction, whereas with histamine a particularly strong relaxation
was detectable in trachea. In the presence of indomethacin, distal bro
nchus after methacholine and trachea after KCl preconstriction were re
laxed significantly more strongly than the other parts. The relaxation
of the histamine-constricted trachea rings was not increased in compa
rison with that without indomethacin pretreatment. Thus the bronchospa
smolytic effect of HOE 234 varied depending on the pretreatment, metho
d of preconstriction and part of the ah-ways examined. It was stronges
t in trachea rings with histamine preconstriction but its potency was
clearly less than that of salbutamol. The latter had regionally differ
ent effects, being stronger in trachea than in the bronchi for all met
hods of preconstriction. The results suggest that the formation of bro
nchoconstricting prostanoids can attenuate parts of the relaxing effec
t of HOE 234. The possible advantages of HOE 234 as an anti-asthma dru
g might be related to an effect on bronchial hyper-reactivity and mucu
s secretion, because as a direct bronchodilator it is inferior to salb
utamol.